Search hospitals > Texas > Lubbock
Texas Tech University Health Sciences Center
Claim this profileLubbock, Texas 79415
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Lymphoma
Conducts research for Recurrence
165 reported clinical trials
14 medical researchers
Summary
Texas Tech University Health Sciences Center is a medical facility located in Lubbock, Texas. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Lymphoma, Recurrence and other specialties. Texas Tech University Health Sciences Center is involved with conducting 165 clinical trials across 344 conditions. There are 14 research doctors associated with this hospital, such as Alexander Philipovskiy, Chwan-Li (Leslie) Shen, PhD, Mac Ansari, and Mohammad Ansari.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Breast Cancer
Global LeaderHER2 negative
ER positive
PR positive
Top PIs
Alexander PhilipovskiyFlorida Cancer Specialists1 year of reported clinical research
Studies Solid Tumors
Studies Colorectal Cancer
16 reported clinical trials
38 drugs studied
Chwan-Li (Leslie) Shen, PhDTexas Tech University Health Sciences Center1 year of reported clinical research
Studies Mind-Body Exercise
Studies Postmenopausal
6 reported clinical trials
8 drugs studied
Mac AnsariTexas Tech University Health Sciences Center1 year of reported clinical research
Studies Peripheral Vascular Disease
Studies Peripheral Arterial Disease
5 reported clinical trials
8 drugs studied
Mohammad AnsariTexas Tech University Health Sciences Center2 years of reported clinical research
Studies Critical Limb Ischemia
Studies Coronary Artery Disease
4 reported clinical trials
6 drugs studied
Clinical Trials running at Texas Tech University Health Sciences Center
Ovarian Tumors
Surgical Site Infection
Ovarian Carcinoma
Testicular Carcinoma
Ovarian Choriocarcinoma
Kidney Disease
Germ Cell Tumors
Testicular Choriocarcinoma
Testicular Tumor
Chronic Kidney Disease
Chemotherapy
for Cancer
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Drugs used in chemotherapy, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.
Recruiting2 awards Phase 326 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Texas Tech University Health Sciences Center?
Texas Tech University Health Sciences Center is a medical facility located in Lubbock, Texas. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Lymphoma, Recurrence and other specialties. Texas Tech University Health Sciences Center is involved with conducting 165 clinical trials across 344 conditions. There are 14 research doctors associated with this hospital, such as Alexander Philipovskiy, Chwan-Li (Leslie) Shen, PhD, Mac Ansari, and Mohammad Ansari.